Sangamo Biosciences reported $-43977000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Avrobio Inc AVRO:US $ -29833000 1.61M
Bayer BAYN:GR € 1161M 1076M
IONIS PHARMACEUT IONS:US $ 225M 307.47M
Novartis NOVN:VX SF 16308M 13550M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Ziopharm Oncology ZIOP:US $ -9.79M 2.01M